PATENT CLAIM ANALYSIS

Application Number: 16209600
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "001210"]

Abstract:
The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that promote transport of a pharmaceutical agent to the lymphatic system and subsequently enhance release of the parent drug.

Claim (Index 43):
A compound of formula (III): wherein R 1  and R 2  independently represent H or a residue of a C 2 -C 28  fatty acid; \u2014X\u2014 is \u2014O\u2014; represents a residue of a pharmaceutical agent;\n -L- is \u2014X\u2032\u2014 or \u2014X\u2032C(O)\u2014; \n X\u2032 is O, S, or N(R 4 ); \n \u2014Z\u2014 is \u2014C(O)\u2014 or \u2014C(O)R 3 \u2014 when -L- is \u2014X\u2032\u2014; or \n \u2014Z\u2014 is absent when -L- is \u2014X\u2032C(O)\u2014; \n R 3  is a self-immolative group; and \n R 4  is H or C 1 -C 4 alkyl; \n R 5  and R 6  are individually selected from hydrogen and C 1 -C 4 alkyl; and \n n is from 1 to 18; \n provided that one or both of R 5  and R 6  are C 1 -C 4 alkyl; \n or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 98.0
- Lexical Diversity: 1.3
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15113986', '14965549', '12364310', '15750471', '11329267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.743118450275628
- 35 USC 102 Novelty (BERT): 0.5204882544912068
- Combined Prediction Score: 0.7208554306971858
- Mean Citation Score: 279.354174
- Max Citation Score: 284.09033
- Similarity Product: 181.49943092961792

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test